8 Hour Pain Relief Tablet, Extended Release
NDC Package 83324-082-50
Package Information
8 Hour Pain Relief (acetaminophen) tablets is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a tablet, extended release delivery system. Marketed by Chain Drug Marketing Association, Inc., this product is identified by NDC 83324-082 and is authorized under FDA application ANDA211544.
Identification & Billing
- RxCUI: 1148399 - acetaminophen 650 MG 8HR Extended Release Oral Tablet
- RxCUI: 1148399 - 8 HR acetaminophen 650 MG Extended Release Oral Tablet
- RxCUI: 1148399 - 8 HR APAP 650 MG Extended Release Oral Tablet
- RxCUI: 1148399 - acetaminophen 650 MG 8 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83324 - Chain Drug Marketing Association, Inc.
- 83324-082 - 8 Hour Pain Relief
- 83324-082-50 - 1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 83324-082 - 8 Hour Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83324-082-50 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet, extended release in 1 bottle, plastic of 8 Hour Pain Relief, a human over the counter drug labeled by Chain Drug Marketing Association, Inc.. This tablet, extended release is formulated for oral use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Marketing Association, Inc. on May 01, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Chain Drug Marketing Association, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83324008250. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.